
Job Title: Equity Research Associate – Rare Diseases
Reports to: Sr. Equity Research Analyst
Department: Equity Research
Location: Boston
Salary Range: $110,000-$150,000
This individual will work closely with senior equity research professionals to prepare research reports and other products to help investor clients evaluate the clinical and commercial prospects of biotechnology therapies in development for rare and common diseases. PhD or MD and equity research experience strongly preferred. The ideal candidate will have a strong understanding of biology and finance, work ethic, critical thinking and communication skills. Additionally, we want a candidate who is versatile, creative, a skilled writer, and not afraid to dig into tough topics.
Primary Duties and Responsibilities:
Experience and Qualifications Required:
About Leerink Partners, LLC
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.
Equal Employment Opportunity
Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices.
Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made.

Leerink Partners is a highly specialized healthcare investment bank with a legacy of excellence in the financial industry. The firm’s experienced team delivers innovative advisory solutions, capital raising expertise, and unique insights to empower clients to achieve their strategic objectives. Since inception the firm has advised on over $70 billion, helped clients raise over $180 billion and has established itself as a trusted partner to healthcare companies and their investors. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.